MC1675A1 - Dérivés de dihydropyridine - Google Patents
Dérivés de dihydropyridineInfo
- Publication number
- MC1675A1 MC1675A1 MC851776A MC1776A MC1675A1 MC 1675 A1 MC1675 A1 MC 1675A1 MC 851776 A MC851776 A MC 851776A MC 1776 A MC1776 A MC 1776A MC 1675 A1 MC1675 A1 MC 1675A1
- Authority
- MC
- Monaco
- Prior art keywords
- alkyl
- group
- nitrophenyl
- dihydro
- isopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH309784 | 1984-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1675A1 true MC1675A1 (fr) | 1986-06-03 |
Family
ID=4248551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC851776A MC1675A1 (fr) | 1984-06-27 | 1985-06-25 | Dérivés de dihydropyridine |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4742069A (instruction) |
| EP (1) | EP0166422A1 (instruction) |
| JP (1) | JPS6118762A (instruction) |
| CN (1) | CN85105335A (instruction) |
| AU (1) | AU4399185A (instruction) |
| DK (1) | DK288085A (instruction) |
| ES (2) | ES8609253A1 (instruction) |
| FI (1) | FI852359L (instruction) |
| GR (1) | GR851554B (instruction) |
| HU (1) | HU193784B (instruction) |
| IL (1) | IL75595A0 (instruction) |
| MC (1) | MC1675A1 (instruction) |
| NO (1) | NO852576L (instruction) |
| PH (1) | PH21510A (instruction) |
| PT (1) | PT80719B (instruction) |
| ZA (1) | ZA854665B (instruction) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
| CN106011652B (zh) | 2016-06-28 | 2017-12-26 | 宝山钢铁股份有限公司 | 一种磷化性能优异的冷轧低密度钢板及其制造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2639498A1 (de) * | 1976-09-02 | 1978-03-09 | Bayer Ag | Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2747513A1 (de) * | 1977-10-22 | 1979-05-03 | Bayer Ag | Dihydropyridine mit schwefelhaltigen estergruppierungen |
| SE429652B (sv) * | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
| DE3116129A1 (de) * | 1981-04-23 | 1982-11-11 | Hoechst Ag, 6000 Frankfurt | 2-ketosulfonamide und verfahren zu ihrer herstellung |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
-
1985
- 1985-06-13 FI FI852359A patent/FI852359L/fi not_active Application Discontinuation
- 1985-06-17 US US06/745,743 patent/US4742069A/en not_active Expired - Fee Related
- 1985-06-20 ZA ZA854665A patent/ZA854665B/xx unknown
- 1985-06-21 IL IL75595A patent/IL75595A0/xx unknown
- 1985-06-24 HU HU852464A patent/HU193784B/hu unknown
- 1985-06-24 AU AU43991/85A patent/AU4399185A/en not_active Abandoned
- 1985-06-25 EP EP85107835A patent/EP0166422A1/de not_active Withdrawn
- 1985-06-25 PH PH32451A patent/PH21510A/en unknown
- 1985-06-25 MC MC851776A patent/MC1675A1/fr unknown
- 1985-06-25 DK DK288085A patent/DK288085A/da not_active Application Discontinuation
- 1985-06-25 GR GR851554A patent/GR851554B/el unknown
- 1985-06-26 ES ES544558A patent/ES8609253A1/es not_active Expired
- 1985-06-26 NO NO852576A patent/NO852576L/no unknown
- 1985-06-26 JP JP60138052A patent/JPS6118762A/ja active Pending
- 1985-06-26 PT PT80719A patent/PT80719B/pt unknown
- 1985-07-12 CN CN198585105335A patent/CN85105335A/zh active Pending
-
1986
- 1986-01-31 ES ES551817A patent/ES8705388A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT80719B (en) | 1987-04-23 |
| ES8609253A1 (es) | 1986-09-01 |
| AU4399185A (en) | 1986-01-02 |
| IL75595A0 (en) | 1985-10-31 |
| DK288085A (da) | 1985-12-28 |
| ES8705388A1 (es) | 1987-05-01 |
| EP0166422A1 (de) | 1986-01-02 |
| ES544558A0 (es) | 1986-09-01 |
| DK288085D0 (da) | 1985-06-25 |
| JPS6118762A (ja) | 1986-01-27 |
| HUT37923A (en) | 1986-03-28 |
| FI852359A0 (fi) | 1985-06-13 |
| US4742069A (en) | 1988-05-03 |
| CN85105335A (zh) | 1987-01-14 |
| GR851554B (instruction) | 1985-11-25 |
| PH21510A (en) | 1987-11-10 |
| HU193784B (en) | 1987-11-30 |
| NO852576L (no) | 1985-12-30 |
| FI852359A7 (fi) | 1985-12-28 |
| PT80719A (en) | 1985-07-01 |
| ZA854665B (en) | 1986-02-26 |
| ES551817A0 (es) | 1987-05-01 |
| FI852359L (fi) | 1985-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI70573B (fi) | Analogifoerfarande foer framstaellning av terapeutiskt aktiv 2,6-dimetyl-4-2,3-diklorfenyl-1,4-dihydro- pyridin-3,5-dikarboxsylsyra-3-metylester-5-etylester | |
| EP0370901B1 (fr) | Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant | |
| JP2703408B2 (ja) | １，４‐ベンゾチアゼピン誘導体 | |
| WO1993003013A1 (fr) | Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant | |
| JP2000507270A (ja) | 新規置換２，４―チアゾリジンジオン誘導体、その製造方法およびそれを含む薬剤組成物 | |
| FR2562892A1 (fr) | Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes | |
| KR100513302B1 (ko) | 3-아미노-1,2-벤조이소옥사졸 유도체, 이의 제조방법및 용도 | |
| EP0069664B1 (fr) | Amidobenzamides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant | |
| EP0109866B1 (fr) | Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| FR2688781A1 (fr) | Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant. | |
| EP0240398B1 (fr) | Dérivés dissymétriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procédés de préparation et utilisation en thérapeutique | |
| EP0096890A2 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives | |
| MC1675A1 (fr) | Dérivés de dihydropyridine | |
| FR2602231A1 (fr) | Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2536072A1 (fr) | Nouveaux derives de la quinazoline, leur preparation et leur utilisation comme medicaments | |
| FR2532310A1 (fr) | Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| RU2081869C1 (ru) | Производные 1,4-дигидропиридина и фармацевтическая композиция на их основе, обладающая вазоактивным действием | |
| EP0105881B1 (fr) | Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant | |
| FR2531433A1 (fr) | Nouveaux alcaloides de l'ergot de seigle, leur preparation et leur utilisation comme medicaments | |
| EP0212107A1 (de) | 1,4-Dihydro-5-sulfamoyl-nicotinsäureester | |
| EP0158211B1 (fr) | Nouveaux dérivés de 1,4 dihydropyridine, leur procédé de préparation, et leur application comme médicaments | |
| JPH0699458B2 (ja) | ジヒドロピリジン−５−ホスホン酸環状エステル類 | |
| EP0430800B1 (fr) | Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| EP0095451A2 (en) | Novel dihydropyridines | |
| WO1987004439A1 (en) | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |